Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek ...

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its price objective lowered by HC Wainwright from $14.00 to $11.00 ...

Shares of NASDAQ RVPH opened at $1.91 on Friday. Reviva Pharmaceuticals has a twelve month low of $0.60 and a twelve month high of $4.83. The firm has a 50-day moving average of $1.71 and a two ...

CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

EF Hutton has initiated coverage on Reviva Pharmaceuticals (NASDAQ: RVPH), issuing a Buy rating with a price target of $15.00. The firm's optimism is primarily driven by the ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

1 Day RVPH -4.71% DJIA 0.65% Russell 2K -1.03% Health Care/Life Sciences -0.52% ...